Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Search

Total 154 results found. Search for [ Dilip Shanghvi ]

Results 1 to 21 of 154
BusinessToday.In
August 14, 2018
The Sun Pharma stock closed 6.91% or 38.90 points higher to 601 level on the BSE today. The stock which closed at 562 level yesterday rose 46 points or 8.05% to an intra day high of 608 level on the BSE.


E Kumar Sharma
New Delhi, June 13, 2018
The development is a hugely positive development both for Sun Pharma and for Indian pharma. From a sentiment perspective, it is significant given that the company has been finally able to get its facility cleared after three years.


PTI
June 12, 2018



E Kumar Sharma
New Delhi, May 25, 2018
Just prior to the results, on May 23, Sun Pharma had announced that the US drug regulator USFDA (US Food and Drug Administration) approved Yonsa, its drug to treat a kind of prostate cancer.


BusinessToday.In
New Delhi, May 7, 2018
The Ambani family, including the once-estranged brother Anil Ambani, will come together at Antilia to celebrate the weddings.


BusinessToday.in
New Delhi, March 7, 2018
With USD 8.8 billion, Savitri Jindal is the richest Indian woman on the list.


PTI
March 7, 2018



BusinessToday.in
New Delhi, February 14, 2018
Sun Pharma in a BSE filing said that its net profit was adversely impacted by one-time deferred tax adjustment of Rs 513 crore related to changes in US tax rates.


PTI
February 2, 2018



Niti Kiran
December 26, 2017
Mukesh Ambani saw the highest jump in his net worth YTD in dollar terms.He was followed by Adani group's founder Gautam Adani whose net worth increased $5.6billion YTD.


Dilip Shanghvi
New Delhi, December 23, 2017
The potential of people comes out when you give them challenging assignments, empower them and give them the space to make mistakes.


P.B. Jayakumar
New Delhi, December 11, 2017
Margin erosion and regulatory hurdles are hitting Indian pharma companies hard in their biggest market.


E. Kumar Sharma
New Delhi, November 25, 2017
Pharma stocks continue to underperform as policy uncertainty adds to the toll taken by USFDA and market challenges.


BT Online
New Delhi, November 14, 2017
The company had posted a net profit of Rs 2,235.14 crore for the corresponding period of the previous fiscal.


Mail Today Bureau
October 6, 2017
Despite India's economic hiccups, tycoons on the 2017 Forbes India rich list saw their wealth soar with their combined fortunes rising 26 per cent to USD 479 billion.


BT Online
New Delhi, October 5, 2017
There was an increase of 26 per cent in the aggregate wealth of the top 100 richest people.


BT Online
September 26, 2017
Balkrishna owns close to 94 per cent of Patanjali Ayurved and is the brain behind the admirable growth of Patanjali as a consumer brand. Patanjali has secured a second place in Indian FMCG market share in under 5 years.


E Kumar Sharma
New Delhi, August 17, 2017
On August 3rd, the largest generic company operating in the US, Teva Pharmaceutical Industries (Teva in quickspeak) put out results that arguably jolted the world of global generic medicines.


PTI
New Delhi, June 8, 2017
\"Amazing thing is that a lot of this going to happen because India will become data rich before it becomes rich.


Reuters
New Delhi, May 27, 2017
The world's fifth-largest generic drugs maker is the latest to offer a bleak US forecast, echoing recent comments by rivals Dr Reddy's Laboratories Ltd and Lupin Ltd.


PAGES 1 OF 8  12345